Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers
暂无分享,去创建一个
Kunihiko Kobayashi | K. Kaira | H. Kagamu | O. Yamaguchi | A. Mouri | H. Imai | A. Shiono | K. Hashimoto | Y. Miura | T. Akagami | S. Shinomiya | K. Kobayashi